Otros idiomas Ultimovacs ASA

Acciones

ULTI

NO0010851603

Mercado cerrado - Oslo Bors Otros sitios de cotización 16:45:00 06/06/2024			Varia. Cinco días.	Varia. 1 de enero.
7,55 ^NOK	0,00 %		-17,03 %	-93,85 %

07/05	Transcript : Ultimovacs ASA, Q1 2024 Earnings Call, May 07, 2024
07/05	Ultimovacs ASA informa de los resultados del primer trimestre finalizado el 31 de marzo de 2024	CI

Otros idiomas

Desbloquee todas las noticias: ¡Sea el primero en enterarse y reaccione antes que los mercados!

Inscripción 100% Gratuita

Ultimovacs : INITIUM Poster presentation at ASCO, June 1, 2024	01/06
Ultimovacs Announces Poster Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting	01/06
Ultimovacs Announces Poster Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting	01/06
Ultimovacs : presentation per May 7, 2024	21/05
Ultimovacs Q1 2024 - Survival mode	07/05
Ultimovacs ASA Reports First Quarter 2024 Financial Results and Provides General Business Update	07/05
Ultimovacs ASA Reports Earnings Results for the First Quarter Ended March 31, 2024	07/05
Ultimovacs ASA: Invitation to first quarter 2024 results webcast presentation	30/04
Ultimovacs Announces Poster Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting	24/04
Ultimovacs ASA – Annual General Meeting held on April 18, 2024	18/04
Ultimovacs to Reduce 40% of Workforce Amid Operational Adjustments	17/04
Ultimovacs Implements Operational Adjustments to Support Continuous Advancement of the UV1 Vaccine Phase II Program	16/04
Ultimovacs Implements Operational Adjustments to Support Continuous Advancement of the UV1 Vaccine Phase II Program	16/04
Ultimovacs ASA Implements Operational Adjustments to Support Continuous Advancement of the UV1 Vaccine Phase II Program	16/04
Ultimovacs - Invitation to Business Update on April 17, 2024	09/04
Ultimovacs – Invitation to Business Update on April 17, 2024	09/04
Ultimovacs to Present Poster at the American Association for Cancer Research (AACR) Annual Meeting 2024	04/04
Ultimovacs : TENDU trial Poster presentation at AACR 2024	02/04
Ultimovacs : Company Presentation as per March 23, 2024	25/03
Ultimovacs ASA: Notice of Annual General Meeting on April 18, 2024	25/03

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Ultimovacs ASA

Acciones

ULTI

NO0010851603

Otros idiomas

Filtros